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INTRODUCTION
Owing to being shared vascular supply and anatomical
proximity and hold the pancreatic duct in common, spleen
or duodenum is considered to be resected together with the
pancreas in case of resection of tail of pancreas or head of pan-
creas. However, advance in surgical skill and surgical anato-
my makes the organ-preserving pancreatectomy possible. 
Until now, various types of organ-preserving pancreatec-
tomy have been introduced such as duodenum-preserving
pancreatic head resection (DPPHR), pancreatic head resec-
tion with segmental duodenectomy (PHRSD), central pan-
createctomy (CP), ventral pancreatectomy (1), segmental resec-
tion of pancreas (2), ductal branch-oriented minimal pancre-
atectomy (3), and spleen-preserving distal pancreatectomy
(SPDP). It has been suggested that a limited resection has
the advantage of preserving function of the pancreas and the
organs around pancreas (4-8). However, its clinical usefulness
is not well established due to the technical difficulty, ambi-
guity of functional merit and limited number of cases.
In this study, to determine the clinical efficacy and feasibil-
ity of the organ-preserving pancreatectomy, we retrospectively
analyzed the clinical outcomes of various type of organ-pre-
serving pancreatectomy and compared with those of conven-
tional pancreatectomy such as pylorus-preserving pancreati-
coduodenectomy (PPPD) and distal pancreatectomy. 
MATERIALS AND METHODS
Between 1995 and 2007, the duodenum-preserving resec-
tion of the head of the pancreas (DPRHP) was performed in
14 patients, the PHRSD in 16 patients, the CP in 14 patients,
and the SPDP in 45 patients at the Department of Surgery,
Seoul National University Hospital, Seoul, Korea. They were
preoperatively diagnosed as benign lesions or tumors with
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Clinical Efficacy of Organ-Preserving Pancreatectomy for Benign or
Low-Grade Malignant Potential Lesion
The clinical usefulness of organ-preserving pancreatectomy is not well established
due to technical difficulty and ambiguity of functional merit. The purpose of this study
is to evaluate the clinical efficacy of organ-preserving pancreatectomy such as duo-
denum-preserving resection of the head of the pancreas (DPRHP), pancreatic head
resection with segmental duodenectomy (PHRSD), central pancreatectomy (CP)
and spleen-preserving distal pancreatectomy (SPDP). Between 1995 and 2007,
the DPRHP were performed in 14 patients, the PHRSD in 16 patients, the CP in 13
patients, and the SPDP in 45 patients for preoperatively diagnosed benign lesions
or tumors with low-grade malignant potential. The clinical outcomes including sur-
gical details, postoperative complications and long-term functional outcomes were
compared between organ-preserving pancreatectomy and conventional pancrea-
tectomy group. Major postoperative complications constituted the following: bile
duct stricture (7.1% [1/14]) in DPRHP, delayed gastric emptying (31.2% [5/16]) in
PHRSD, pancreatic fistula (21.4% [3/14]) in CP. There were no significant differ-
ences in postoperative complications and long-term functional outcomes between
two groups. Organ-preserving pancreatectomy is associated with tolerable postop-
erative complications, and good long-term outcome comparing to conventional pan-
createctomy. Organ-preserving pancreatectomy could be alternative treatment for
benign or low-grade malignant potential lesion of the pancreas or ampullary/para-
papillary duodenum.
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Accepted : 1 March 2009low-grade malignant potential at the pancreas or ampullary/
parapapillary duodenum. During the same period, the PPPD
and the distal pancreatectomy (DP), which are classified as
kinds of the conventional pancreatectomy, were performed
in 70 patients and in 143 patients, respectively for benign
lesions or tumors with low-grade malignant potential at the
pancreas or ampullary/parapapillary duodenum.
The DPRHP and PHRSD were performed in the same
manner as described in our previous report (9) (Fig. 1, 2). For
the CP, SPDP, and DP, proximal stump of the pancreas was
reinforced with suture by 4-0 black silk and 5-0 polypropy-
lene (prolene*, Ethicon, Somerville, NJ, USA). The main pan-
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Fig. 1. Schematic diagram of the duodenal-preserving resection of the head of the pancreas (adopted from ref.9, Arch Surg 2003;138:162-8).
(A) Operative procedure of DPRHP. ASPDA indicates anterior superior pancreaticoduodenal artery. (B) View after the total resection of
the head of the pancreas, pancreatogastrostomy, T tube insertion, and pancreatic diversion were performed.
AIPDA, anterior inferior pancreaticoduodenal artery; CBD, common bile duct; GDA, gastroduodenal artery; GEA, gastroepiploic artery;
SMV, superior mesenteric vein.
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Fig. 2. Schematic diagram of the pancreas head resection with segmental duodenectomy (adopted from ref.9, Arch Surg 2003;138:162-
8). (A) Operative procedure of PHRSD. (B) View after the resection, a pancreatogastrostomy, an end-to-side choledochoduodenostomy
with a T-tube stent, and an end-to-end duodenoduodenostomy were performed.
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CBDcreatic duct in proximal stump was ligated with non-absor-
bable suture directly. In the CP, pancreaticogastrostomy or
pancreaticojejunostomy with two-layer duct-to-mucosa anas-
tomosis technique were performed to the distal stump. In
the SPDP, both splenic artery and vein were preserved.
Clinical data were obtained from the patient’s medical
records (surgical reports, pathologic reports, postoperative
data, hospital course, and outpatient medical records). The
surgical factors (including operation time, estimated blood
loss, and transfusion) and postoperative complications were
analyzed. The postoperative long-term outcomes (endocrine
and exocrine function, recurrence, and weight change) were
also evaluated. We divided the organ-preserving pancreatec-
tomy into two types according to the location of lesion, i.e.,
pancreatic head or ampullary/parapapillary duodenum and
pancreatic body/tail. We compared the DPRHP and the PH-
RSD with the PPPD for lesion of head of the pancreas or am-
pullary/parapapillary duodenum, and compared the CP and
the SPDP with DP for the lesion of the body or tail of the
pancreas.
Data from multiple determinations were expressed as mean
±standard deviation. We used a chi-square test and Fisher
exact test for categorical comparison of data. Differences in
the means of continuous measurements were tested with the
Mann-Whitney U test. P values of less than 0.05 were con-
sidered significant.
RESULTS
Table 1 lists the patient’s demographics and postoperative
diagnosis. There were no significant differences in age, sex,
and postoperative diagnosis between the DPRHP and the
PPPD, between the PHRSD and the PPPD, between the
CP and the DP, and between the SPDP and the DP. In the
PHRSD, there were 5 patients diagnosed as malignant dis-
ease. The final diagnosis of 2 patients having villous adenoma
on the preoperative endoscopic biopsy specimen was proved
to be an early duodenal cancer. On the postoperative patho-
logic report, it was shown to be well differentiated adenocar-
cinoma confined to mucosa. A patient with a metastatic renal
cell carcinoma had a history of a radical nephrectomy for renal
cell carcinoma 8 yr prior to PHRSD. The preoperative radi-
ologic diagnosis was a nonfunctioning islet cell tumor of the
pancreas. The preoperative diagnosis of a patient having pan-
creatic cancer was intraductal papillary mucinous neoplasm.
On the postoperative pathologic report, it was shown to be
a moderately differentiated adenocarcinoma, extending beyond
pancreas, bile duct and pancreatic soft tissue. And the last
one whose preoperative diagnosis was intraductal papillary
mucinous neoplasm was proven as invasive intraductal pap-
illary mucinous carcinoma. In the SPDP, there was one patient
diagnosed as malignant disease. The patient with a metastat-
ic carcinoma in lymph node had a history of a left hemihep-
atectomy for combined hepatocellular and cholangiocarci-
noma 2 yr before SPDP. Because the metastatic lymph node
was so closely attached to pancreatic parenchyma and could
not be dissected from parenchyma, SPDP was performed.
On the postoperative pathologic report, there was no parenchy-
mal invasion of carcinoma.
Surgical factors
Table 2 shows the perioperative factors and there were no
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*Epidermal cyst, chronic pancreatitis, pseudocyst, etc.; 
� Duodenal cancer, pancreatic cancer, intraductal papillary mucious carcinoma, metastatic
renal cell carcinoma; 
� intraductal papillary mucious carcinoma, malignant islet cell tumor; 
�Metastatic hepatocelluar carcinoma.
DPRHP, duodenum-preserving pancreatic head resection; PHRSD, pancreatic head resection with segmental duodenectomy; PPDD, pylorus-pre-
serving pancreaticoduodenectomy; CP, central pancreatectomy; SPDP, spleen-preserving distal pancreatectomy; DP, distal pancreatectomy. 
P value
DPRHP
(n=14)
Parameters
PPPD 
(n=70)
PHRSD
(n=16) DPRHP vs.
PPPD
PHRSD vs.
PPPD
P value
CP
(n=14)
DP
(n=143)
SPDP
(n=45) CP vs.
DP
SPDP vs.
DP
Age (yr) 47±14 56±10 56±14 0.065 0.952 46±75 0 ±14 52±15 0.046 0.101
Male:Female 1:1.8 1:1.3 1.5:1 0.143 0.254 1:3.5 1:1.6 1:1.7 0.126 0.235
Diagnosis 0.442 0.551 0.341 0.424
Benign
Cystic neoplasm 6 3 8 8 16 44
Intraductal papillary 4 2 15 1 8 19
mucinous neoplasm
Solid pseudopapillary 1 0 2 2 8 16
neoplasm
Islet cell tumor 2 2 6 2 5 9
Tubovillous adenoma of 0 4 15 0 0 0
ampulla of Vater
Others* 1 0 11 1 7 34
Malignant 0 5
� 13
� 01
� 22
�
Table 1. Patient’s demographics and postoperative diagnosessignificant differences in operation time, estimated blood loss,
and intraoperative transfusion between the DPRHP and the
PPPD, between the PHRSD and the PPPD, between the CP
and the DP, and between the SPDP and the DP.
Postoperative complications and hospital course
Table 2 shows the postoperative complications of the pro-
cedures and postoperative hospital stay. Pancreatic leakage
was defined as drainage of more than 30 mL of fluid with an
amylase level higher than 600 U/dL on or after postoperative
week 1 (10). Pancreatic leakages were detected in 3 (18.8%
[3/16]) patients who underwent PHRSD and in 3 patients
(21.4% [3/14]) who underwent CP. All the patients in whom
pancreatic leakages occurred recovered well with conserva-
tive management with percutaneous drainage and short-peri-
od fasting. There was no significant difference between the
PHRSD and the PPPD group and between the CP and the
DP group.
Major postoperative bleeding presenting as gastrointesti-
nal tract bleeding occurred in one patient who underwent
PHRSD, after hospital discharge. This patient required an
additional operation to control the bleeding from the inferi-
or pancreaticoduodenal vessels caused by a leakage from the
pancreaticogastrostomy site. There was no significant differ-
ence in pseudoaneurysm between the PHRSD and the PPPD
group.
There was no hospital mortality associated with surgical
complication.
Delayed gastric emptying was defined as nasogastric drai-
nage for more than 10 days, or a reinsertion of a nasogastric
tube because of vomiting, or a failure to tolerate a semisolid
diet 14 days after surgery (11). In 5 (5/16 [31.3%]) patients
who underwent PHRSD, delayed gastric emptying developed,
and was managed conservatively with a complete recovery.
There was no significant difference in delayed gastric emp-
tying development between PHRSD and PPPD group. Hos-
pital stay was longer in PHRSD group than in PPPD group
for management of delayed gastric emptying (P=0.034).
In one patient with intraductal papillary mucinous neo-
plasm who underwent DPRHP, obstructive jaundice due to
a focal bile duct stricture developed a few days after hospital
discharge. We routinely insert a T tube for all the patients
who underwent the DPRHP and the patient’s condition was
managed successfully by an interventional balloon dilatation
through the T tube tract. The patient has been healthy with
normal liver function for 30 months. 
There was one patient who had the potential for splenic
infarct after SPDP. On the computed tomography (CT) scan
4 yr after surgery, the appearance of volume loss with multi-
focal low attenuated lesions at the spleen with intact splenic
artery was seen without any overt symptom. The patient is
still alive without problems 7 yr after the surgery.
Splenic vein thrombosis occurred in one patient who under-
went DP due to hematologic disease. He received anticoag-
ulation treatment. There was no more progression of the
thrombosis. Portal vein thrombosis occurred in three patients
after distal pancreatectomy. They received no specific treat-
ment, and thrombosis was improved on radiologic image
study. 
There was one patient who was suspected as overwhelm-
ing postsplenectomy sepsis (OPSI) after distal pancreatecto-
my and he was only one patient who experienced septic shock
in our study. Intravenous antibiotics treatment was performed
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DPRHP, duodenum-preserving pancreatic head resection; PHRSD, pancreatic head resection with segmental duodenectomy; PPDD, pylorus-pre-
serving pancreaticoduodenectomy; CP, central pancreatectomy; SPDP, spleen-preserving distal pancreatectomy; DP, distal pancreatectomy; DGE,
Delayed gastric emptying; OPSI, Overwhelming postsplenectomy sepsis.
P value
DPRHP
(n=14)
Factors
PPPD 
(n=70)
PHRSD
(n=16) DPRHP 
vs. PPPD
PHRSD vs.
PPPD
P value
CP
(n=14)
DP
(n=143)
SPDP
(n=45) CP vs.
DP
SPDP vs.
DP
Operation time (min) 380±98 369±53 337±62 0.202 0.072 228±67 223±130 211±94 0.668 0.514
Estimated blood loss (mL) 411±209 417±240 443±300 0.780 0.774 292±530 384±241 477±749 0.411 0.519
Intraoperative transfusion  0 0 5 (7.1%) 0.219 0.218 1 (7.1%) 2 (4.4%) 11 (7.7%) 0.932 0.628
(yes)
Pancreatic leakage 1 (7.1%) 3 (18.8%) 10 (14.3%) 0.625 0.225 3 (21.4%) 6 (13.3%) 21 (14.7%) 0.590 0.875
Pseudoaneurysm 0 1 (6.3%) 2 (2.9%) 0.439 0.479 0 0 0
Intra-abdominal abscess 1 (7.1%) 2 (12.5%) 7 (10.0%) 0.924 0.660 1 (7.1%) 3 (6.7%) 11 (7.7%) 0.968 0.977
DGE 0 5 (31.3%) 12 (17.1%) 0.283 0.149 0 0 0
Bile duct stricture 1 (7.1%) 0 0 0.057 0 0 0
Portal vein thrombosis 0 0 0 0 0 3 (2.1%) 0.239
OPSI 0 0 0 0 0 1 (0.7%) 0.498
Postoperative hospital stay  22±15 30±11 23±10 0.873 0.034 17±71 6 ±91 5 ±9 0.842 0.758
(days)
Hospital mortality 0 0 0 0 0 0
Table 2. Comparison of perioperative factorsand his medical condition had been improved. There was no
hospital mortality associated with this study.
Long-term outcomes of patients
Long-term outcomes were followed to keep track of pan-
creatic endocrine and exocrine function, weight change, gas-
trointestinal tract symptoms, and disease recurrence (Table 3).
Regarding the endocrine function, 6 patients had diabetes
mellitus and 2 patients had insulinoma with hypoglycemia
preoperatively in organ-preserving pancreatectomy group.
Normoglycemia was obtained after removing the insulino-
ma. Newly developed diabetes mellitus was noted in 1 patient
after PHRSD and in 7 patients after PPPD, and there was
no significant difference between two groups. Newly devel-
oped diabetes mellitus was noted in 4 patients after SPDP
and in 16 patients after DP, there was no significant difference
between two groups. Three patients complained of postop-
erative steatorrhea with intermittent abdominal cramping
pain in the early posthospital days after PHRSD. One of the
aforementioned patients is still suffering from postprandial
diarrhea and severe steatorrhea. The others recovered within
3 months postoperatively. There were 6 patients who suffered
from steatorrhea after PPPD and no significant difference
between PHRSD and PPPD group. Weight loss was defined
as loss of weight more than 10% of their preoperative body
weight during the postoperative 3 months. Weight loss was
detected in two patients who underwent the PHRSD and
14 patients after PPPD. There was no significant difference
between the two groups. Symptoms of cholangitis, which
might occur due to choledochoduodenostomy, were not ob-
served in any patient after PHRSD. There was no evidence
of recurrence in all the patients who underwent organ-pre-
serving pancreatectomy including two patients with early
duodenal cancer and pancreatic cancer at 31 and 28 months
after the operation, respectively. There were four patients who
experienced recurrence after PPPD. They underwent PPPD
for intraductal papillary mucinous carcinoma or malignant
islet cell tumor and liver metastasis occurred during follow-
up period. There were two patients with recurrence who un-
derwent distal pancreatectomy for intraductal papillary muci-
nous neoplasm, borderline and malignant islet cell tumor.
DISCUSSION
Pancreaticoduodenectomy and DP with splenectomy are
standard operation for patients with pancreatic neoplasm with
the introduction of the concept of less invasive surgery and
in consideration of postoperative quality of life, for patients
with benign lesions or low-grade malignant potential tumor,
other parenchymal sparing or spleen-preserving techniques
are attempted. 
Despite the improvement of operative technique, materials
and instruments, pancreatic fistula after pancreaticoduodenc-
tomy is the most common and serious complication. Recent
large series have reported that the failure rate of the pancre-
aticoenteric anastomosis is 9-18% (12-16). In our study, the
rate of pancreatic leakage was 7.1% in DPRHP group and
18.8% in PHRSD group. In PHRSD group, the rate is slight-
ly higher than in PPPD group (14%), but the difference was
not significant. The cause of high incidence of pancreatic lea-
kage after PHRSD was uncertain. In all cases with pancre-
atic leakage, there was no history of pancreatitis. Their pan-
creatic parenchyma, however, were soft and it was thought
to be the main reason of the leakage. The results of this study
suggest that the weak point of CP was a high risk of pancre-
atic leakage. The leakage rate after CP was 21.3%, which
was slightly higher than PPPD or DP group. However, the
differences were not significant between CP and PPPD group
(data was not shown), and between CP and DP group. The
rate of pancreatic leakage after CP is reported up to 60% (17,
18). The high incidence may be a result of the creation of two
pancreatic remnants with CP, each of which is a potential source
of pancreatic leakage.
Delayed gastric emptying, which is non-life-threatening
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P value
DPRHP
(n=14)
PPPD 
(n=70)
PHRSD
(n=16) DPRHP 
vs. PPPD
PHRSD vs.
PPPD
P value
CP
(n=14)
DP
(n=143)
SPDP
(n=45) CP vs.
DP
SPDP vs.
DP
Follow-up period (months) 32±20 31±18 42±38 0.095 0.087 30±21 33±29 36±33 0.494 0.624
Diabetes mellitus
Newly developed 0 1 (6.3%) 7 (10.0%) 0.143 0.846  0 4 (8.9%) 16 (11.2%) 0.477 0.898
Unchanged 1 (7.1%) 1 (6.3%) 24 (34.3%) 0.022 0.036 0 4 (8.9%) 16 (11.2%) 0.477 0.898
Aggravated 0 0 0 0 0 0
Steatorrhea 0 1 (6.3%) 6 (8.6%) 0.177 0.694 0 0 0
Weight loss 0 2 (12.5%) 14 (20.0%) 0.240 0.846 0 0 0
Recurrence 0 0 4 (5.7%) 0.235 0.218 0 0 2 (1.4%) 0.570 0.337
Table 3. Long-term outcome after surgery
DPRHP, duodenum-preserving pancreatic head resection; PHRSD, pancreatic head resection with segmental duodenectomy; PPDD, pylorus-pre-
serving pancreaticoduodenectomy; CP, central pancreatectomy; SPDP, spleen-preserving distal pancreatectomy; DP, distal pancreatectomy. 
Outcomescomplication, has been described as one of the leading causes
of postoperative morbidity after PPPD, occurring up to 50%
of patients (19-21) and after PHRSD occurring up to 38%
(22). In our study, delayed gastric emptying occurred in no
patient after DPRHP and in 5 patients (31% [5/16]) after
PHRSD. And there was significant difference between the
DPRHP and the PHRSD group (P=0.051). The reason of
these results is not clear, however, it was surmised that duo-
denectomy might disrupt the coordination of gastric and in-
testinal motility. And preservation of the duodenum in DP-
RHP seem to be more physiologic and showed better results
over PHRSD or PPPD.
Only one biliary complication from DPRHP was experi-
enced. This patient had a stricture of the distal common bile
duct, which was successfully managed by dilatation and tem-
porary stenting. A focal ischemia or a sealed-off microperfo-
ration might be the cause of the stricture, which appears to
be a procedure (DPRHP)-related complication. 
Splenectomy in conjunction with DP is clearly indicated in
most patients with adenocarcinoma of the pancreas, as splenic
preservation may compromise the oncologic resection. How-
ever, for benign and low-grade malignant disease, the issue
of splenic preservation may have a role. Splenic-preservation
has been performed because of consideration of overwhelm-
ing postsplenetomy sepsis (23, 24) and immunologic func-
tion of the spleen (25, 26). In our study, there were no signifi-
cant differences in postoperative complication rate, operative
time, or length of postoperative hospitalization between SPDP
and DP group. However we experienced one case with over-
whelming postsplenectomy sepsis in distal pancreatectomy
group. Although technically demanding, SPDP can be per-
formed safely and has the advantage of reducing the risk of
overwhelming postsplenectomy infection.
The percentage of patients who become diabetic after Whip-
ple’s operation amounts to 20% to 40% (27). A prospective
study performed by Bittner et al. (28) to evaluate the endo-
crine pancreatic function following DPRHP showed in most
patients, DPRHP did not lead to an impairment of glucose
tolerance. In our study, one patient (7%) became diabetic after
PHRSD and 4 patients (11%) became diabetic after SPDP.
Their diabetes mellitus were under control with taking oral
hypoglycemic drugs.
Organ-preserving pancreatectomy is associated with tol-
erable perioperative risk, postoperative complications, and
good long-term outcome in the aspects of preservation of
function and curability in tumors with low-grade malignant
potential when compared to conventional pancreatectomy.
Organ-preserving pancreatectomy could be alternative treat-
ment for benign or low-grade malignant potential lesions of
pancreas or ampullary/parapapillary duodenum. Even then,
organ-preserving pancreatectomy will be suitable for only a
small group of patients and should only be performed by
experienced surgeons. 
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